In vitro evaluation of papaverine hydrochloride incompatibilities: a simulation of intraarterial infusion for cerebral vasospasm

AJNR Am J Neuroradiol. 1994 Oct;15(9):1665-70.

Abstract

Purpose: To elucidate, in light of reports of complications associated with intraarterial infusion of papaverine hydrochloride, the known propensity of papaverine hydrochloride to form precipitate in combination with other solutions or pharmaceuticals.

Methods: Initially simulating a situation experienced during an intraarterial papaverine infusion for cerebral vasospasm, we mixed various concentrations of papaverine with serum, nonheparinized and heparinized saline, and nonionic contrast material.

Results: Papaverine in concentrations of 0.3% (300 mg/100 mL of normal saline) or greater formed a precipitate when mixed with human serum (blood). The precipitate crystals were 50 to 100 microns in size and could be returned to solution simply by the addition of more serum.

Conclusion: Crystal emboli are a possible transient cause of complications experienced during treatment of vasospasm with its attendant altered flow dynamics.

MeSH terms

  • Cerebral Angiography*
  • Chemical Precipitation
  • Crystallization
  • Dose-Response Relationship, Drug
  • Drug Incompatibility
  • Humans
  • Injections, Intra-Arterial
  • Iohexol / adverse effects
  • Iohexol / pharmacokinetics
  • Ischemic Attack, Transient / blood
  • Ischemic Attack, Transient / diagnostic imaging
  • Ischemic Attack, Transient / drug therapy*
  • Models, Cardiovascular*
  • Papaverine / administration & dosage
  • Papaverine / adverse effects*
  • Papaverine / pharmacokinetics
  • Spectrophotometry

Substances

  • Iohexol
  • Papaverine